Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Runhua Liu M.D., Ph.D.
Associate Professor
Close
E-mail
runhua@uab.edu
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Runhua Liu M.D., Ph.D.
Associate Professor
Positions
Associate Scientist
,
Cancer Cell Biology
,
O'Neal Comprehensive Cancer Center
Associate Professor (P)
,
Genetics Research Division
,
Genetics
2012 -
Associate Scientist (C)
,
O'Neal Comprehensive Cancer Center
,
School of Medicine
2013 -
Publications
Research
Teaching
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2020
Fibrinogen Alpha Chain Knockout Promotes Tumor Growth and Metastasis through Integrin-AKT Signaling Pathway in Lung Cancer.
2020
2019
MicroRNA-1205, encoded on chromosome 8q24, targets EGLN3 to induce cell growth and contributes to risk of castration-resistant prostate cancer
2019
2019
Loss of FOXP3 and TSC1 accelerates prostate cancer progression through synergistic transcriptional and posttranslational regulation of c-Myc
2019
2018
FOXP3 activates SUMO-conjugating UBC9 gene in MCF7 breast cancer cells
2018
2017
MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer
2017
2017
Jun dimerization protein 2 activates Mc2r transcriptional activity: Role of phosphorylation and SUMOylation
2017
2016
Silencing of CD24 enhances the PRIMA-1-induced restoration of mutant p53 in prostate cancer cells
2016
2015
FOXP3 controls an MIR-146/NF-κB negative feedback loop that inhibits apoptosis in breast cancer cells
2015
2015
FOXP3-MIR-146-NF-κB axis and therapy for precancerous lesions in prostate
2015
2014
SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells
2014
Research
Principal Investigator On
Synergistic Targeted Therapy of Antibody-Drug Conjugates for Triple-Negative Breast Cancer
awarded by
National Cancer Institute/NIH/DHHS
2020 - 2024
Effects of CD24-RCC2 Signaling on Prostate Cancer Metastasis
awarded by
DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY
2015 - 2020
Utilizing microRNA-146a to Block Triple-Negative Breast Cancer Cell Colonization
awarded by
National Cancer Institute/NIH/DHHS
2019 - 2020
Investigator On
3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership
awarded by
National Cancer Institute/NIH/DHHS
2016 - 2021
Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Project 1: CD24-Dependent Inactivation of Mutant p53 in Metastatic Castration-Resistant Prostate Cancer
awarded by
National Cancer Institute/NIH/DHHS
2016 - 2021
Epigenome Editing for Targeted Reactivation of X- Linked FOXP3 to Treat Breast Cancers
awarded by
DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY
2017 - 2020
Synergistic Action of FOXP3 and TSC1 Pathways During Tumor Progression
awarded by
DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY
2014 - 2018
Roles of Semaphorin Signaling in Breast Cancer Racial Disparities
awarded by
National Cancer Institute/NIH/DHHS
2015 - 2018
MicroRNAs for Monitoring Tumor Progression and Predicting Response to Therapy
awarded by
National Cancer Institute/NIH/DHHS
2014 - 2017
FOXP3-microRNA146-NFkB Axis in Tumor Suppression
awarded by
National Cancer Institute/NIH/DHHS
2012 - 2015
Teaching
Teaching Activities
GBSC718 - Epigenetics (Spring Term 2020)
2020
GBSC718 - Epigenetics (Spring Term 2019)
2019
GGSC320 - Colloquium-Genetics/Genomics (Fall Term 2018)
2018
GBSC718 - Epigenetics (Spring Term 2018)
2018
GBSC718 - Epigenetics (Summer Term 2017)
2017
Background
Education And Training
Doctor of Philosophy Level Degree in Medical Genetics,
University of Miyazaki
2002
Contact
Full Name
Runhua
Liu
